The Claim

Men aged 30–75 years who initiate testosterone therapy without documented biochemical hypogonadism have a 51% higher risk of major adverse cardiovascular events over 10 years compared to men with documented biochemical hypogonadism, with a hazard ratio of 1.51 (95% CI 1.45–1.56), indicating that the prescribing context of testosterone therapy influences long-term cardiovascular outcomes.

Source: Off-label testosterone therapy is associated with higher long-term cardiovascular risk in men

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
67score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect
1 study reviewed
In plain English

Among men aged 30–75, those prescribed testosterone therapy without confirmed low testosterone levels have a 51% higher rate of serious heart problems over 10 years than those prescribed testosterone therapy with confirmed low testosterone levels.

See the scientific wording

Men aged 30–75 years who initiate testosterone therapy without documented biochemical hypogonadism have a 51% higher risk of major adverse cardiovascular events over 10 years compared to those with documented hypogonadism, with hazard ratios of 1.51 (95% CI 1.45–1.56), suggesting that prescribing context significantly influences long-term cardiovascular outcomes.

Why this might work

When men take testosterone without having low testosterone levels, their bodies make too many red blood cells, making the blood thicker. Thick blood flows poorly through small vessels, putting stress on blood vessel walls and causing clots to form. These clots can block arteries in the heart, brain, or other organs, leading to heart attacks, strokes, or cardiac arrest.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Off-label testosterone therapy is associated with higher long-term cardiovascular risk in men

    Men who got testosterone therapy without being officially diagnosed with low testosterone had a much higher chance of heart problems, strokes, or dying over 10 years than men who got it after a confirmed diagnosis. This suggests doctors should be more careful about who they prescribe it to.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.